{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:37:12Z","timestamp":1785317832682,"version":"3.55.0"},"reference-count":115,"publisher":"VM Media Group sp. z o.o","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rpor.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T18:02:22Z","timestamp":1572458542000},"page":"629-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cardiotoxicity of mediastinal radiotherapy"],"prefix":"10.5603","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-6616","authenticated-orcid":false,"given":"Ivica","family":"Ratosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ivanetic Pantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"key":"10.1016\/j.rpor.2019.09.002_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma\u2014target definition and dose guidelines from the international lymphoma radiation oncology group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.08.003","article-title":"The role of radical radiotherapy in the management of malignant pleural mesothelioma: a systematic review","volume":"125","author":"Ashton","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0015","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2019.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0025","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1056\/NEJMoa1209825","article-title":"Ischemic heart disease after breast cancer radiotherapy","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2019.09.002_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiotherapy: a systematic review of heart doses published during 2003-2013","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol"},{"issue":"12","key":"10.1016\/j.rpor.2019.09.002_bib0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14779072.2018.1538785","article-title":"Radiation and the heart: systematic review of dosimetry and cardiac endpoints","volume":"16","author":"Niska","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.rpor.2019.09.002_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0050","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non\u2013small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv008","article-title":"Risk for valvular heart disease after treatment for hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.rpor.2019.09.002_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0065","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for hodgkin disease: a collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.rpor.2019.09.002_bib0075","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.rpor.2019.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the childhood cancer survivor study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpor.2019.09.002_bib0095","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3109\/0284186X.2015.1016624","article-title":"Predicting radiation-induced valvular heart damage","volume":"54","author":"Cella","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpor.2019.09.002_bib0115","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1200\/JCO.2010.33.4730","article-title":"High risk of symptomatic cardiac events in childhood cancer survivors","volume":"30","author":"van der Pal","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2017.74.8673","article-title":"Prediction of ischemic heart disease and stroke in survivors of childhood cancer","volume":"36","author":"Chow","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1748-717X-1-10","article-title":"3-D reconstruction of anterior mantle-field techniques in Hodgkin\u2019s disease survivors: doses to cardiac structures","volume":"1","author":"Vordermark","year":"2006","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-8140(94)90008-6","article-title":"Cardiac lesions after mediastinal irradiation for Hodgkin\u2019s disease","volume":"30","author":"Glanzmann","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.2011.08713.x","article-title":"Review of the cardiac long-term effects of therapy for Hodgkin lymphoma","volume":"154","author":"Ng","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0140","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1002\/cam4.1572","article-title":"Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis","volume":"7","author":"Boyne","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.rpor.2019.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-8140(97)00125-4","article-title":"Cardiac risk after mediastinal irradiation for Hodgkin\u2019s disease","volume":"46","author":"Glanzmann","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rpor.2019.09.002_bib0160","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","article-title":"Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies","volume":"55","author":"Schellong","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0165","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"cardiovascular status in long-term survivors of hodgkin\u2019s disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0170","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2019.09.002_bib0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2017.09.008","article-title":"Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls","volume":"125","author":"van Rosendael","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2014.01.021","article-title":"Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis","volume":"89","author":"Girinsky","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18690\/actabiomed.149","article-title":"Atherosclerosis, epigenetic modifications, and arterial stiffnes","volume":"10","author":"Piko","year":"2017","journal-title":"Acta Medico-Biotechnica"},{"key":"10.1016\/j.rpor.2019.09.002_bib0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ctrv.2010.12.004","article-title":"Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease","volume":"37","author":"van Leeuwen-Segarceanu","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rpor.2019.09.002_bib0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease","volume":"25","author":"Heidenreich","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0200","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amjcard.2014.04.055","article-title":"Left ventricular function in long-term survivors of childhood lymphoma","volume":"114","author":"Christiansen","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","article-title":"Asymptomatic cardiac disease following mediastinal irradiation","volume":"42","author":"Heidenreich","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amjcard.2015.11.027","article-title":"Assessment of valvular disorders in survivors of Hodgkin\u2019s lymphoma treated by mediastinal radiotherapy \u00b1 chemotherapy","volume":"117","author":"Bijl","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clon.2015.03.005","article-title":"Involved node, site, field and residual volume radiotherapy for lymphoma: a comparison of organ at risk dosimetry and second malignancy risks","volume":"27","author":"Murray","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjc.6605191","article-title":"Valvular dysfunction and left ventricular changes in Hodgkin\u2019s lymphoma survivors. A longitudinal study","volume":"101","author":"Wethal","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood-2010-06-291328","article-title":"Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation","volume":"117","author":"Galper","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2019.09.002_bib0230","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0235","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/hrt.75.6.591","article-title":"Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin\u2019s disease: an echocardiographic study","volume":"75","author":"Lund","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.rpor.2019.09.002_bib0240","first-page":"234","article-title":"Mini-review on cardiac complications after mediastinal irradiation for Hodgkin lymphoma","volume":"66","author":"van Rijswijk","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.rpor.2019.09.002_bib0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2011.08.040","article-title":"Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin\u2019s lymphoma","volume":"101","author":"Cella","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-2-13","article-title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin\u2019s lymphoma: reduction in normal tissue dose and second cancer risk","volume":"2","author":"Koh","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0255","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","article-title":"Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma","volume":"83","author":"Maraldo","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0260","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pbc.24861","article-title":"The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma","volume":"61","author":"Maraldo","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0265","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.12.048","article-title":"Dosimetric comparison of three different involved nodal irradiation techniques for stage ii hodgkin\u2019s lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy","volume":"75","author":"Chera","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0270","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","article-title":"Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma","volume":"84","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmrs.219","article-title":"A case study evaluating deep inspiration breath-hold and intensity-modulated radiotherapy to minimise long-term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma","volume":"64","author":"Tomaszewski","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.rpor.2019.09.002_bib0280","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2011.06.1959","article-title":"Consolidative involved-node proton therapy for stage IA-IIIB mediastinal hodgkin lymphoma: preliminary dosimetric outcomes from a phase II study","volume":"83","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0285","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0295","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin\u2019s lymphoma","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0300","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/0284186X.2014.932435","article-title":"Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold","volume":"54","author":"Petersen","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-018-1066-2","article-title":"Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation","volume":"13","author":"Baues","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0310","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canrad.2015.11.002","article-title":"Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin\u2019s lymphoma female patients receiving involved-field or involved site radiation therapy","volume":"20","author":"Horn","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.rpor.2019.09.002_bib0315","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijrobp.2010.05.007","article-title":"Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0320","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) lymphoma subcommittee","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0325","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2019.09.002_bib0330","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","article-title":"Late cardiac toxicity after mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction","volume":"98","author":"Hahn","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2019.09.002_bib0335","unstructured":"N. Kristina Gregory, O. Miranda Hughes, D.E. Wood, et al., National Comprehensive Cancer Network. Thymomas and thymic carcinomas (version 2.2018). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thymic_blocks.pdf. Accessed February 10, 2018"},{"key":"10.1016\/j.rpor.2019.09.002_bib0340","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ejca.2012.02.047","article-title":"Rare thoracic cancers, including peritoneum mesothelioma","volume":"48","author":"Siesling","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0345","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0350","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijsu.2018.04.018","article-title":"The role of postoperative radiation therapy for completely resected stage III thymoma and effect of higher heart radiation dose on risk of cardiovascular disease: a retrospective cohort study","volume":"53","author":"Liao","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.rpor.2019.09.002_bib0355","article-title":"Risk of coronary events 55 years after thymic irradiation in the hempelmann cohort","volume":"4","author":"Adams","year":"2018","journal-title":"Cardio Oncol (London, England)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0360","doi-asserted-by":"crossref","first-page":"S1743","DOI":"10.1097\/JTO.0b013e31821ea60c","article-title":"Radiation therapy definitions and reporting guidelines for thymic malignancies","volume":"6","author":"Gomez","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0365","first-page":"1","article-title":"Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma","author":"Haefner","year":"2018","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0370","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/tlcr.2018.04.06","article-title":"Rationale and early outcomes for the management of thymoma with proton therapy","volume":"7","author":"Zhu","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.rpor.2019.09.002_bib0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cllc.2016.05.019","article-title":"Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities","volume":"17","author":"Parikh","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0380","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/0284186X.2017.1302097","article-title":"Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies","volume":"56","author":"Vogel","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0385","article-title":"DIBH (Deep Inspiratory Breath Hold)-based radiotherapy \u2013 a clinical review","author":"Boda-Heggemann","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0390","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jmrs.89","article-title":"The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review","volume":"62","author":"Smyth","year":"2015","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.rpor.2019.09.002_bib0395","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2018.08.2036","article-title":"Current and future management of malignant mesothelioma: a consensus report from the national cancer institute thoracic malignancy steering committee, international association for the study of lung cancer, and mesothelioma applied research foundation","volume":"13","author":"Tsao","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0400","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.canrad.2017.05.007","article-title":"High dose irradiation after pleurectomy\/decortication or biopsy for pleural mesothelioma treatment","volume":"21","author":"Parisi","year":"2017","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.rpor.2019.09.002_bib0405","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.prro.2015.07.010","article-title":"Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma","volume":"5","author":"Kishan","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0410","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.rpor.2017.07.006","article-title":"Malignant pleural mesothelioma \u2013 Pleural cavity irradiation after decortication with helical tomotherapy","volume":"22","author":"Harrabi","year":"2017","journal-title":"Reports Pract Oncol Radiother"},{"key":"10.1016\/j.rpor.2019.09.002_bib0415","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2011.11.057","article-title":"Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0420","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0425","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2011.09.025","article-title":"Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series","volume":"101","author":"Tonoli","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0430","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1118\/1.4735684","article-title":"SU-E-T-595: comparison of Volumetric Modulated Arc Therapy (VMAT) and Static Intensity Modulated Radiotherapy (IMRT) for malignant pleural mesothelioma in patients with intact lungs\/post pleurectomy","volume":"39","author":"Dumane","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.rpor.2019.09.002_bib0435","article-title":"Proton therapy for malignant pleural mesothelioma: a three case series describing the clinical and dosimetric advantages of proton-based therapy","volume":"9","author":"Lee","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.rpor.2019.09.002_bib0440","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.prro.2014.11.005","article-title":"Early experience with intensity modulated proton therapy for lung-intact mesothelioma: a case series","volume":"5","author":"Pan","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0445","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.08.003","article-title":"The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review","volume":"125","author":"Ashton","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0455","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00066-011-0038-3","article-title":"Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma","volume":"188","author":"Lorentini","year":"2012","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0460","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijrobp.2009.11.006","article-title":"Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy","volume":"78","author":"Krayenbuehl","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0465","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27050","article-title":"Acute toxicity of craniospinal irradiation with volumetric-modulated arc therapy in children with solid tumors","volume":"65","author":"Wong","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0470","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0475","first-page":"238","article-title":"Craniospinal irradiation using helical tomotherapy for central nervous system tumors","volume":"58","author":"Schiopu","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.rpor.2019.09.002_bib0480","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2010.07.1987","article-title":"optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s)","volume":"81","author":"JMAM","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0485","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijrobp.2010.12.033","article-title":"Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning","volume":"82","author":"Lee","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9153496","article-title":"Radiotherapy for adult medulloblastoma: evaluation of helical tomotherapy, volumetric intensity modulated arc therapy, and three-dimensional conformal radiotherapy and the results of helical tomotherapy therapy","volume":"2018","author":"Zong-wen","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.rpor.2019.09.002_bib0495","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1259\/bjr\/13776022","article-title":"High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy","volume":"82","author":"Sharma","year":"2009","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0500","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1088\/1361-6560\/aa6c9e","article-title":"Out-of-field doses from pediatric craniospinal irradiations using 3D-CRT, IMRT, helical tomotherapy and electron-based therapy","volume":"62","author":"De Saint-Hubert","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0505","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1080\/0284186X.2018.1465588","article-title":"Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)","volume":"57","author":"Seravalli","year":"2018","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0510","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(03)01574-8","article-title":"Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medullobla stoma","volume":"58","author":"Clair","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0515","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/0284186X.2017.1324207","article-title":"A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma","volume":"56","author":"Ho","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.rpor.2019.09.002_bib0520","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.radonc.2014.07.003","article-title":"A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation","volume":"113","author":"Zhang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rpor.2019.09.002_bib0530","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2019.09.002_bib0535","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbmt.2016.12.623","article-title":"Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis","volume":"23","author":"Friedman","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.rpor.2019.09.002_bib0540","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1055-9965.EPI-09-0555","article-title":"Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study","volume":"19","author":"Meacham","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.rpor.2019.09.002_bib0545","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.rpor.2019.09.002_bib0550","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.24252","article-title":"Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age","volume":"60","author":"Mulcahy Levy","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0555","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2011.118","article-title":"Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation","volume":"47","author":"Baker","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rpor.2019.09.002_bib0560","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/pbc.24702","article-title":"Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years","volume":"60","author":"K\u00fcnkele","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0565","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00066-014-0607-3","article-title":"Long-term results of total body irradiation in adults with acute lymphoblastic leukemia","volume":"190","author":"Marnitz","year":"2014","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.rpor.2019.09.002_bib0570","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/cncr.31114","article-title":"Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma","volume":"124","author":"Myers","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.rpor.2019.09.002_bib0575","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41409-018-0155-z","article-title":"Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation","volume":"53","author":"Duncan","year":"2018","journal-title":"Bone Marrow Transplant"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136719300720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136719300720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T08:18:07Z","timestamp":1695370687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136719300720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1507136719300720"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2019.09.002","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity of mediastinal radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}